Artemis Medicare Services Schedules Board Meeting on May 8, 2026 to Approve Q4FY26 Financial Results

Artemis Medicare Services has informed the stock exchanges of a forthcoming Board of Directors meeting scheduled for May 8, 2026 (Friday), pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting has been convened to consider key financial and shareholder-related matters for the quarter and year ended March 31, 2026.

Key Agenda Items

The board meeting has been called to address two primary matters, as outlined in the company's exchange filing dated May 5, 2026:

Approval of Audited Financial Results: The board will consider and approve the Audited Financial Results on both a Standalone and Consolidated basis for the quarter and year ended March 31, 2026.

Dividend Recommendation: The board will deliberate on recommending a dividend, if any, on the equity shares of the company for the year ended March 31, 2026.

Meeting and Trading Window Details

The following table summarises the key details related to the board meeting and the associated trading window closure:

Parameter: Details Board Meeting Date: May 8, 2026 (Friday) Financial Period Under Review: Quarter and year ended March 31, 2026 Results Type: Standalone & Consolidated Trading Window Closure Start: April 1, 2026 Trading Window Reopens: May 10, 2026 (48 hours post-result declaration) Filing Date: May 5, 2026

Trading Window Closure

As communicated by the company vide its earlier intimation dated March 30, 2026, the trading window for dealing in the securities of Artemis Medicare Services was closed from April 1, 2026. The window shall remain closed until 48 hours after the declaration of audited financial results, i.e., up to May 10, 2026 (both days inclusive). This closure is in accordance with the applicable insider trading regulations.

The intimation was signed by Poonam Makkar, Company Secretary & Compliance Officer, on behalf of Artemis Medicare Services Limited.

Artemis medicare services Limited has submitted its mandatory compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The healthcare services company filed the certificate with both the National Stock Exchange of India Limited and BSE Limited on April 6, 2026.

Regulatory Filing Details

The compliance certificate was submitted pursuant to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. Company Secretary and Compliance Officer Poonam Makkar signed the filing on behalf of Artemis Medicare Services Limited.

Filing Parameter: Details Quarter Ended: March 31, 2026 Filing Date: April 6, 2026 Regulation: SEBI (Depositories and Participants) Regulations, 2018 Specific Provision: Regulation 74(5)

Registrar Confirmation

Alankit Assignments Limited, serving as the registrar and transfer agent, provided the compliance certificate confirming proper handling of dematerialization processes. Kamal Garg, General Manager at Alankit Assignments Limited, digitally signed the certificate on April 6, 2026.

The registrar confirmed that securities comprised in physical share certificates received for dematerialization have been properly processed. The certificate states that after due verification, physical certificates were mutilated and cancelled, with the depository name being substituted in records as the registered owner.

Compliance Framework

The filing demonstrates Artemis Medicare Services Limited's adherence to SEBI's regulatory framework governing depositories and participants. The quarterly compliance certificate ensures transparency in the dematerialization process and maintains investor confidence in the electronic settlement system.

Alankit Assignments Limited holds multiple SEBI registrations and operates from its registered office in New Delhi, providing comprehensive registrar and transfer agent services to listed companies.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.